Table 1 Ten cancer-related lncRNAs used for model construction
From: A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
Symbol | ID | HR | Low 95% CI | High 95% CI | P value | Coefficient |
|---|---|---|---|---|---|---|
RP11-573D15.8 | ENSG00000197099 | 2.2151 | 1.4438 | 3.3982 | 0.0003 | 0.7953 |
LINC01317 | ENSG00000203386 | 1.5029 | 0.9733 | 2.3205 | 0.0661 | 0.4074 |
RNF144A-AS1 | ENSG00000228203 | 1.8097 | 0.9352 | 3.5019 | 0.0782 | 0.5932 |
TFAP2A-AS1 | ENSG00000229950 | 1.3016 | 0.9183 | 1.8449 | 0.1386 | 0.2636 |
LINC00702 | ENSG00000233117 | 1.7035 | 0.9748 | 2.9767 | 0.0614 | 0.5327 |
GAS6-AS1 | ENSG00000233695 | 0.5416 | 0.3708 | 0.7912 | 0.0015 | − 0.6131 |
RP11-400K9.4 | ENSG00000237807 | 0.4318 | 0.2353 | 0.7925 | 0.0067 | − 0.8397 |
LUCAT1 | ENSG00000248323 | 1.4199 | 1.0692 | 1.8857 | 0.0154 | 0.3506 |
RP11-63A11.1 | ENSG00000250781 | 0.5133 | 0.3423 | 0.7695 | 0.0012 | − 0.6670 |
RP11-156L14.1 | ENSG00000265702 | 0.5251 | 0.3029 | 0.9104 | 0.0218 | − 0.6442 |